222 related articles for article (PubMed ID: 11238946)
1. beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter.
Hapke S; Gawaz M; Dehne K; Köhler J; Marshall JF; Graeff H; Schmitt M; Reuning U; Lengyel E
Mol Cell Biol; 2001 Mar; 21(6):2118-32. PubMed ID: 11238946
[TBL] [Abstract][Full Text] [Related]
2. Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor.
Besta F; Massberg S; Brand K; Müller E; Page S; Grüner S; Lorenz M; Sadoul K; Kolanus W; Lengyel E; Gawaz M
J Cell Sci; 2002 Oct; 115(Pt 20):3879-88. PubMed ID: 12244126
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the urokinase receptor (u-PAR)--a central molecule of invasion and metastasis.
Fuchs T; Allgayer H
Biol Chem; 2003 May; 384(5):755-61. PubMed ID: 12817472
[TBL] [Abstract][Full Text] [Related]
4. Effects of mutations in the cytoplasmic domain of integrin beta(1) to talin binding and cell spreading.
Kääpä A; Peter K; Ylänne J
Exp Cell Res; 1999 Aug; 250(2):524-34. PubMed ID: 10413605
[TBL] [Abstract][Full Text] [Related]
5. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
6. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene.
Lengyel E; Wang H; Stepp E; Juarez J; Wang Y; Doe W; Pfarr CM; Boyd D
J Biol Chem; 1996 Sep; 271(38):23176-84. PubMed ID: 8798512
[TBL] [Abstract][Full Text] [Related]
7. Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice.
Besta F; Müller I; Lorenz M; Massberg S; Bültmann A; Cabeza N; Richter T; Kremmer E; Nothdurfter C; Brand K; Gawaz M
Thromb Res; 2004; 114(4):283-92. PubMed ID: 15381392
[TBL] [Abstract][Full Text] [Related]
8. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
[TBL] [Abstract][Full Text] [Related]
9. Role of urokinase receptor and caveolin in regulation of integrin signaling.
Chapman HA; Wei Y; Simon DI; Waltz DA
Thromb Haemost; 1999 Aug; 82(2):291-7. PubMed ID: 10605716
[TBL] [Abstract][Full Text] [Related]
10. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
Xue W; Mizukami I; Todd RF; Petty HR
Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
[TBL] [Abstract][Full Text] [Related]
12. The NITY motif of the beta-chain cytoplasmic domain is involved in stimulated internalization of the beta3 integrin A isoform.
Gawaz M; Besta F; Ylänne J; Knorr T; Dierks H; Böhm T; Kolanus W
J Cell Sci; 2001 Mar; 114(Pt 6):1101-13. PubMed ID: 11228154
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line.
Kita D; Takino T; Nakada M; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Nov; 61(21):7985-91. PubMed ID: 11691823
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.
Leupold JH; Yang HS; Colburn NH; Asangani I; Post S; Allgayer H
Oncogene; 2007 Jul; 26(31):4550-62. PubMed ID: 17297470
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the promoter for the alpha3 integrin gene in various tumor cell lines: roles of the Ets- and Sp-family of transcription factors.
Katabami K; Kato T; Sano R; Ogura M; Mizuno H; Itoh S; Tsuji T
J Cell Biochem; 2006 Feb; 97(3):530-43. PubMed ID: 16211576
[TBL] [Abstract][Full Text] [Related]
16. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
Schewe DM; Biller T; Maurer G; Asangani IA; Leupold JH; Lengyel ER; Post S; Allgayer H
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8538-48. PubMed ID: 16361535
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers.
Schewe DM; Leupold JH; Boyd DD; Lengyel ER; Wang H; Gruetzner KU; Schildberg FW; Jauch KW; Allgayer H
Clin Cancer Res; 2003 Jun; 9(6):2267-76. PubMed ID: 12796395
[TBL] [Abstract][Full Text] [Related]
18. A conserved sequence motif in the integrin beta3 cytoplasmic domain is required for its specific interaction with beta3-endonexin.
Eigenthaler M; Höfferer L; Shattil SJ; Ginsberg MH
J Biol Chem; 1997 Mar; 272(12):7693-8. PubMed ID: 9065427
[TBL] [Abstract][Full Text] [Related]
19. Identification of a talin-binding site in the integrin beta(3) subunit distinct from the NPLY regulatory motif of post-ligand binding functions. The talin n-terminal head domain interacts with the membrane-proximal region of the beta(3) cytoplasmic tail.
Patil S; Jedsadayanmata A; Wencel-Drake JD; Wang W; Knezevic I; Lam SC
J Biol Chem; 1999 Oct; 274(40):28575-83. PubMed ID: 10497223
[TBL] [Abstract][Full Text] [Related]
20. Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression.
Wang H; Yan C; Asangani I; Allgayer H; Boyd DD
Oncogene; 2007 Mar; 26(14):2058-70. PubMed ID: 17001307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
